TipRanks
Advertisement
Advertisement
Botanix Pharmaceuticals Options Lapse, Streamlining Capital Structure
PremiumCompany AnnouncementsBotanix Pharmaceuticals Options Lapse, Streamlining Capital Structure
1M ago
Botanix Pharm: Strong Sofdra Adoption and Margin Upside Support Buy Rating with Unchanged $1 Price Target
Premium
Ratings
Botanix Pharm: Strong Sofdra Adoption and Margin Upside Support Buy Rating with Unchanged $1 Price Target
1M ago
Botanix files updated ASX corporate governance statement for 2026
Premium
Company Announcements
Botanix files updated ASX corporate governance statement for 2026
1M ago
Botanix: Sofdra Launch Momentum and Revenue Recovery Support Unchanged $1 Price Target and Buy Rating
PremiumRatingsBotanix: Sofdra Launch Momentum and Revenue Recovery Support Unchanged $1 Price Target and Buy Rating
2M ago
Botanix boosts Sofdra sales, tightens costs and fortifies IP as cash position strengthens
Premium
Company Announcements
Botanix boosts Sofdra sales, tightens costs and fortifies IP as cash position strengthens
2M ago
Botanix Seeks ASX Quotation for 10.3 Million New Shares
Premium
Company Announcements
Botanix Seeks ASX Quotation for 10.3 Million New Shares
4M ago
Botanix issues investor update with detailed disclaimers and risk caveats
PremiumCompany AnnouncementsBotanix issues investor update with detailed disclaimers and risk caveats
5M ago
Botanix builds Sofdra momentum, fortifies balance sheet and supply chain
Premium
Company Announcements
Botanix builds Sofdra momentum, fortifies balance sheet and supply chain
5M ago
Botanix Director Granted Options Linked to Share Placement
Premium
Company Announcements
Botanix Director Granted Options Linked to Share Placement
5M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―